Drug Development for Cancer and Diabetes

A Path to 2030
Herausgeber: Bahadur, Bir; Kannan, S.; Elavarasi, S.; Saravanan, K.; Averal, Horne Iona; Egbuna, Chukwuebuka

• Broschiertes Buch

Produktbeschreibung

Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Apple Academic Press Inc.
• Seitenzahl: 362
• Erscheinungstermin: 28. Februar 2022
• Englisch
• Abmessung: 156mm x 233mm x 24mm
• Gewicht: 632g
• ISBN-13: 9781774634936
• ISBN-10: 1774634937
• Artikelnr.: 62800032

Autorenporträt

K. Saravanan, PhD, is Associate Dean of Academic Affairs and Assistant Professor of Zoology, Nehru Memorial College, an affiliated institution of Bharathidasan University, Tamilnadu, India. He has been engaged in teaching, research, and writing for over 15 years. Chukwuebuka Egbuna is a chartered chemist, a chemical analyst, and an academic researcher. He has had many roles at New Divine Favor Pharmaceutical Industry Limited, Nigeria, and Chukwuemeka Odumegwu Ojukwu University, Nigeria. He has published research articles on phytochemistry as well as the 3-volume book Phytochemistry with AAP. Horne Iona Averal, PhD, is Associate Professor at Holy Cross College, Trichy, India. She has received many awards and honors and has been engaged with many academic roles at several colleges and universities. Dr. Averal has published four nucleotide sequences in the NCBI-GENBANK. S. Kannan, PhD, is a specialist in cancer biology and nanomedicine. He has held many roles at national and international academic and scientific bodies and has published a large number of research articles and books in his field. S. Elavarasi, PhD, is Assistant Professor at Holy Cross College, an affiliated institution of Bharathidasan University, Tamilnadu, India. She has been engaged in teaching and research for more than eight years. She has published research articles, book chapters, and books. Bir Bahadur, PhD, was formerly Professor, Chairman, and Head of the Department, as well as Dean of the Faculty of Science at Kakatiya University in Warangal, India. A prolific writer and editor, he received many awards and honors during his long career, including being named as an Eminent Botanist of India.

Inhaltsangabe

PART I CANCER AND LEADS FOR CANCER TREATMENT 1. Biomarkers for Screening of
Premalignant Lesions and Therapeutic Surveillance 2. Kinase Targets in
Cancer Drug Discovery 3. Essential Drug Properties and Stages in
Anti-Cancer Drug Development 4. Plant Constituent as Anti-Cancer Drugs 5.
Anticancer Properties of Some Effective Phytochemicals 6. Therapeutic
Aspects of Some Extracts and Purified Cardiac Glycosides Obtained From
Nerium oleander L 7. Challenging Compounds of Some Medicinal Plants Against
Cancer 8. Medicinal Plants as Therapeutic Agents in the Treatment of Cancer
9. Cytotoxic, Apoptosis Inducing Effects and Anti-Cancerous Drug
Candidature of Jasmonates 10. Apoptosis Activity of 1,2,-Benzene
Dicarboxylic Acid Isolated from Andrographis paniculata on KB, SiHa and IMR
Cancer Cell Line 11. Anticancer Drug Discovery From the Indian Spice Box
12. Phytochemical Investigation and Evaluation of Anti-Breast Cancer
Activity of Chloroform Extract of Tagetes erecta 13. Isolation,
Identification and In Silico Evaluation of Anticancer Activity of Flavone
from Pisum sativum 14. Functional Lead Phytochemicals from the Rutaceae and
Zingeiberaceae Plants for Development of Anticancer Drugs 15. In Vitro
Anticancer Activity of Biophytum sensitivum on Liver Cancer Lines (HEPG2)
16. Saffron and Its Active Ingredients: A Natural Product with Potent
Anticancer Property PART I: ANTIDIABETIC DRUG DISCOVERY 17. Effects of
Pterocarpus marsupium in the Management of Type 2 Diabetes Mellitus 18.
Antidiabetic and Antihyperlipidemic Activities of Cyathea nilgiriensis
(Holttum) on STZ Induced Diabetic Rats 19. Antidiabetic Activity of Drug
Loaded Chitosan Nanoparticle 20. Antidiabetic Activity of Silver
Nanoparticles Biosynthesized Using Ventilago maderaspatana Leaf Extract 21.
Hypoglycemic Activity of Biophytum sensitivum Whole Plant Extracts on
Alloxan Induced Diabetic Rats 22. Antidiabetic Activity of Ventilago
maderaspatana Leaf Extracts on STZ Induced Diabetic Rats 23. Isolation,
Identification, and Molecular Docking of Antidiabetic Compounds of
Cyatheia nilgiriensis (Holttum) 24. Antidiabetic Potentials of Major Indian
Spices: A Review 25. Aloe Species: Chemical Composition and Therapeutic
Uses in Diabetic Treatment